Composite proteomic and metabolomic plasma biomarkers for detection of colorectal, lung and ovarian cancers.
Combining blood proteins and metabolites in one test shows promise for detecting three major cancers earlier than current methods alone.
Uppsala researchers developed a composite proteomic and metabolomic plasma biomarker panel for simultaneous detection of colorectal, lung, and ovarian cancers. Published in Molecular Cancer, this multi-omics approach may complement existing liquid biopsy approaches for multi-cancer early detection.
What the study was
- Study design
- Biomarker discovery and validation study
- Population
- Patients with colorectal, lung, and ovarian cancers
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Molecular cancer
Why it surfaced
Novel multi-omics approach to multi-cancer detection in high-impact journal. Full details limited to abstract.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.